Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1714
https://www.valueinhealthjournal.com/article/S1098-3015(14)03644-4/fulltext
Title :
Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03644-4&doi=10.1016/j.jval.2014.08.1714
First page :
A536
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1188